Test Price
2,800 AED✅ Home Collection Available
ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
Next‑generation sequencing (NGS) of the angiogenin (ANG) gene to confirm a molecular diagnosis of amyotrophic lateral sclerosis type 9 (ALS9).
• Diagnostic accuracy: 99.9% analytical sensitivity & >99% specificity via ISO‑accredited laboratory workflow.
• VIP mobile phlebotomy: Temperature‑controlled cold‑chain home blood collection available daily 8 AM – 11 PM (strictly peripheral whole blood/serum/plasma).
• Post‑test counselling: Free telephone interpretation by a consultant medical geneticist.
• Insurance verification: Direct policy check via WhatsApp (+971 54 548 8731).
Test Overview & Methodology
This diagnostic test identifies pathogenic variants in the ANG gene using next‑generation sequencing (NGS) with MLPA backup for copy‑number variants. The test is indicated for individuals presenting with progressive motor weakness and a family history suggestive of ALS type 9. Results are interpreted by a board‑certified molecular geneticist and correlated with clinical findings.
| Feature | Our Test (ANG NGS) | Alternative: Single‑Gene Sanger |
|---|---|---|
| Precision | 99.9% analytical sensitivity / >99% specificity (deep NGS + CNV detection) | ~98% sensitivity for known point mutations (exons 1–2 only) |
| Methodology | NGS (Next‑Generation Sequencing) + MLPA | Sanger sequencing (no CNV detection) |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Regulatory Approvals | DHA‑approved, ISO 9001:2015 (INT/EGQ/2509DA/3139) | May not carry UAE accreditation |
Physician Insight & Safety Protocols
“Genetic testing for ALS type 9 requires a comprehensive pre‑ and post‑test counselling approach. A positive result may confirm the clinical diagnosis and inform family risk assessment, but it must always be correlated with neurological findings. I strongly recommend that every patient discusses the implications with a qualified neurologist or medical geneticist before proceeding.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID 9294403
Advisory: Medication Continuation
Do not discontinue any prescribed medications (e.g., riluzole, edaravone) without consulting your treating physician. This genetic test is a complementary diagnostic tool and does not replace clinical management.
Safety Exclusion Criteria & Red Flags
- Active infection or febrile illness requiring immediate medical attention – delay specimen collection.
- Known severe coagulation disorder unless a physician‑supervised blood draw is arranged.
- Predictive testing in individuals under 18 years must comply with UAE regulations, including mandatory genetic counselling and guardian consent under Federal Decree‑Law No. 4 of 2016 on Medical Liability and applicable personal data protection laws.
- Suspected acute neurological decompensation (e.g., rapid respiratory decline) – call emergency services (998) before any elective testing.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the ANG gene test, and when can I expect results?
The test identifies pathogenic variants in the angiogenin gene to confirm a diagnosis of ALS type 9, aiding neurologists and genetic counsellors in personalised treatment and family risk planning. Results are typically available within 3 to 4 weeks.
2. Does the price include genetic counselling, and what sample is required?
Yes, the price includes an initial pre‑test genetic counselling session (family tree mapping, risk discussion) and post‑test interpretation. The sample required is a peripheral whole blood specimen (or extracted DNA). Our VIP mobile phlebotomy team can collect it at your home under cold‑chain conditions.
3. Will my health insurance cover this test, and is my genetic data protected?
Many UAE insurers provide coverage when the test is pre‑authorised. We verify your policy via WhatsApp (+971 54 548 8731) and strictly comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 on the Use of ICT in Health Fields to safeguard your genetic information.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled in full compliance with the UAE legal framework:
- Data protection: Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Healthcare ICT security: Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields.
- Medical liability: All clinical procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) + MLPA |
| ICD-10-CM Code | G12.21 |
| LOINC Code | 77772-5 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians